Details for New Drug Application (NDA): 063083
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN HYDROCHLORIDE is clindamycin hydrochloride. There are fifty-five drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the clindamycin hydrochloride profile page.
Summary for 063083
Tradename: | CLINDAMYCIN HYDROCHLORIDE |
Applicant: | Watson Labs |
Ingredient: | clindamycin hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 063083
Physiological Effect | Decreased Sebaceous Gland Activity |
Suppliers and Packaging for NDA: 063083
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 063083 | ANDA | Proficient Rx LP | 63187-556 | 63187-556-20 | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-556-20) |
CLINDAMYCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 063083 | ANDA | Proficient Rx LP | 63187-556 | 63187-556-21 | 21 CAPSULE in 1 BOTTLE, PLASTIC (63187-556-21) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Jul 31, 1991 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 300MG BASE | ||||
Approval Date: | Mar 18, 2003 | TE: | RLD: | No |
Complete Access Available with Subscription